You have no items in your shopping cart.
Cart summary
Recombinant Human VEGF165 Protein, Avi His Tag
Catalog Number: orb1550386
| Catalog Number | orb1550386 |
|---|---|
| Category | Proteins |
| Description | Recombinant Human VEGF165 Protein, Avi His Tag |
| Target | VEGF165 |
| Reactivity | Human |
| Purity | > 95% by Tris-Bis PAGE |
| Expression System | Expi293 |
| Endotoxins | > 95% by Tris-Bis PAGE |
| Source | Recombinant Human VEGF165 Protein is produced by Expi293 expression system. The target protein is expressed with sequence (Ala27-Arg191) of Human VEGF165 fused with a His Tag and Avi tag at the C-terminal. |
| Alternative names | VEGF, VEGFA |
| Note | For research use only |
VEGF121 Protein, Human, Recombinant (His & Avi), Biotinylated [orb1960084]
98.00%
17 kDa (predicted). Due to glycosylation, the protein migrates to 18 kDa and 22-25 kDa under reduced (R) condition, 30 kDa and 32-40 kDa under Non reducing (N) condition based on Tris-Bis PAGE result.
500 μg, 100 μg, 1 mgVEGF121 Protein, Human, Recombinant (His & Avi) [orb1960085]
98.00%
17 kDa (predicted). Due to glycosylation, the protein migrates to 18 kDa and 22-25 kDa under reduced (R) condition, 30 kDa and 32-40 kDa under Non reducing (N) condition based on Tris-Bis PAGE result.
500 μg, 100 μg, 1 mgVEGF165 Protein, Human, Recombinant (His & Avi) [orb1960086]
> 95%
22.2 kDa (predicted). Due to glycosylation, the protein migrates to 28-35 kDa under reduced (R) condition, 45-60 kDa under Non reducing (N) condition based on Tris-Bis PAGE result.
1 mg, 100 μg, 500 μgVEGF165 Protein, Human, Recombinant (His & Avi), FITC-Labeled [orb1960087]
> 95%
22.2 kDa (predicted). Due to glycosylation, the protein migrates to 28-33 kDa under reduced (R) condition, 45-55 kDa under Non reducing (N) condition based on Tris-Bis PAGE result.
1 mg, 500 μg, 100 μgVEGF165 Protein, Human, Recombinant (His & Avi), Biotinylated [orb1954860]
98.10%
23.1 kDa (predicted); 28.3 kDa (reducing condition, due to glycosylation)
20 μg, 100 μg, 200 μg, 500 μg
